Wataru Yamagami
Overview
Explore the profile of Wataru Yamagami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
1197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakamura K, Masuda K, Seki T, Kitago M, Kosaka T, Goto Y, et al.
Keio J Med
. 2025 Mar;
PMID: 40074332
Hereditary breast and ovarian cancer syndrome (HBOC) is traditionally associated with mutations in the BRCA1 and BRCA2 genes, predominantly impacting breast, ovarian, pancreatic, and prostate cancers. However, recent research suggests...
2.
Tamura T, Nagai S, Masuda K, Imaeda K, Sugihara E, Yamasaki J, et al.
Cancer Lett
. 2025 Feb;
616:217565.
PMID: 39971122
Over 50 % of patients with high-grade serous carcinoma (HGSC) are homologous recombination proficient, making them refractory to platinum-based drugs and poly (ADP-ribose) polymerase (PARP) inhibitors. These patients often develop...
3.
Nagase Y, Kodama M, Aimono E, Nakamura K, Takamatsu R, Abe K, et al.
Cancer Sci
. 2025 Feb;
PMID: 39960836
Immune checkpoint inhibitor (ICI) therapy has been successfully applied to various cancers; however, not all patients respond to ICI therapy. Tumors with an immune-activated environment are highly responsive to ICIs....
4.
Konno Y, Mayama M, Takehara K, Yokoyama Y, Suzuki J, Susumu N, et al.
J Gynecol Oncol
. 2025 Feb;
PMID: 39924672
Objective: This study aimed to assess the prognostic significance of para-aortic lymphadenectomy (PALX) and para-aortic lymph node metastasis in endometrial cancer (EC) patients at risk of post-operative recurrence. Methods: Japanese...
5.
Takahashi M, Nakamura K, Chiyoda T, Okada C, Nohara S, Takamatsu R, et al.
Cancer Med
. 2025 Jan;
14(2):e70601.
PMID: 39840716
Background: Borderline ovarian tumors (BOTs) differ from ovarian carcinomas in their clinical presentation and behavior, yet their molecular characteristics remain poorly understood. This study aims to address this gap by...
6.
Adachi T, Matsui T, Okata-Karigane U, Takahashi C, Tahara U, Hyodo M, et al.
J Dermatol
. 2024 Nov;
52(1):132-137.
PMID: 39526614
Immune checkpoint inhibitors (ICIs), such as pembrolizumab (PEM), are widely recognized for their antitumor efficacy, but they can also lead to various cutaneous adverse events (CAEs). While most CAEs can...
7.
Sakai K, Yamagami W, Takahashi F, Tokunaga H, Yamamoto E, Yokoyama Y, et al.
J Gynecol Oncol
. 2024 Nov;
PMID: 39482928
Objective: The prognostic value and clinical usage of peritoneal cytology in endometrial cancer are uncertain. This study aimed to determine whether positive cytology is associated with the prognosis for endometrial...
8.
Takamatsu R, Nakamura K, Chiyoda T, Tsuji K, Kawano R, Yoshimi N, et al.
Arch Pathol Lab Med
. 2024 Oct;
PMID: 39396820
Context.—: Diagnostic strategies for endometrial cancer have been evolving, with cytologic analysis being considered a key method in integrated oncologic diagnostics because of its less invasive nature and adaptability to...
9.
Tsuchino Y, Chiyoda T, Jisaka M, Sakamaki T, Hirata M, Takahashi M, et al.
Gynecol Oncol Rep
. 2024 Jul;
54:101444.
PMID: 39035033
Brain metastasis from ovarian cancer is a very rare condition with a poor prognosis. However, due to its rarity, there is no established treatment strategy. We present a case series...
10.
Hashimoto T, Nakamura Y, Fujisawa T, Imai M, Shibuki T, Iida N, et al.
Cancer Discov
. 2024 Jul;
14(11):2243-2261.
PMID: 39023403
The SCRUM-Japan MONSTAR-SCREEN consortium is a nationwide molecular profiling project employing artificial intelligence-driven multiomics analyses for patients with advanced malignancies, aiming to develop novel therapeutics and diagnostics and deliver effective...